| Literature DB >> 22274538 |
Slava Stamova1, Anja Feldmann, Marc Cartellieri, Claudia Arndt, Stefanie Koristka, Falko Apel, Rebekka Wehner, Marc Schmitz, Martin Bornhäuser, Malte von Bonin, Gerhard Ehninger, Holger Bartsch, Michael Bachmann.
Abstract
There is growing interest in the development of novel single-chain bispecific antibodies for retargeting of immune effector T cells to tumor cells. Until today, functional fusion constructs consisting of a single-chain bispecific antibody and a fluorescent protein were not reported. Such molecules could be useful for an in vivo visualization of this retargeting process. Recently, we established two novel single-chain bispecific antibodies. One is capable of retargeting T cells to CD33, and the other is capable of retargeting T cells to the prostate stem cell antigen (PSCA). CD33 is an attractive immunotarget on the surface of tumor cells from patients with acute myeloid leukemia (AML). The PSCA is a potential target on prostate cancer cells. Flanking the reading frame encoding the green fluorescent protein (GFP) with a recently described novel helical linker element allowed us to establish novel single-chain bispecific fusion antibodies. These fluorescent fusion antibodies were useful to efficiently retarget T cells to the respective tumor cells and visualize the formation of immune synapses between effector and target cells. Copyright ÂEntities:
Mesh:
Substances:
Year: 2012 PMID: 22274538 DOI: 10.1016/j.ab.2011.12.042
Source DB: PubMed Journal: Anal Biochem ISSN: 0003-2697 Impact factor: 3.365